Envoya is at the forefront of biotechnological innovation, specializing in developing non-lipid polymer based nanoparticles for gene therapy.

Dedicated to revolutionizing the gene therapy applications to treat genetic disorders effectively. Our expertise in polymer science and nanotechnology positions us as a key player in the healthcare sector.

At Envoya, we are committed to pushing the boundaries of medical science. Our team of experts leverages profound knowledge and innovative techniques to create smart nanoparticles from polymers to deliver gene therapy safely and effectively. 

Our goal is to fix genetic disorders and improve lives with our cutting-edge technology.  We focus on creating solutions that address the complexities of gene delivery with precision.

Our offerings include:
• Customized Delivery Solutions: Tailoring treatments to meet the specific genetic needs of patients.
• Research and Development in Polymer Science: Innovating at the intersection of polymer science and genetic therapy. 

We believe in the power of science to change lives. We are dedicated to creating a healthier future through our innovative gene therapy delivery solutions.

Contact us today to explore how our advancements in gene therapy delivery can benefit your healthcare goals.
📧info@envoyabio.com
🔗https://www.envoyabio.com/contact

Do visit our website to learn more about how we are leading in science for a better future.
🌐https://www.envoyabio.com/ 

Biotechnology

Life Sciences

Nanotechnology

Envoya Inc.

Shira Orr

Eran Orr

Gilad Meiri

Ori Shaashua

Alysa Langburt

Trinayan Kashyap

Envoya Inc.

Org chart

Similar companies